MedTrace Logo

Multi-parameter Diagnostic Blood Test for the Diagnosis of Alzheimer's Disease

NCT02409030 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 700

Last updated 2019-03-26

No results posted yet for this study

Summary

The purpose of this study is to validate a diagnostic test that combines different blood markers to identify and correctly classify patients with Alzheimer's disease (AD) compared to individuals with behavioural variant frontotemporal dementia (bvFTD, patient control) versus cognitively healthy individuals (healthy control).

Conditions

  • Alzheimer Disease

Sponsors & Collaborators

  • Raman Health Technologies, S.L.

    lead INDUSTRY

Principal Investigators

  • Javier Cabello · Raman Health Technologies, S.L.

Eligibility

Min Age
50 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-01-31
Primary Completion
2016-11-30
Completion
2017-10-18

Countries

  • Belgium
  • France
  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02409030 on ClinicalTrials.gov